T1	Temporal 0 8	Previous
T2	Drug 21 26	drugs
T3	Drug 35 45	fingolimod
T4	Drug 47 58	natalizumab
T5	Drug 60 71	alemtuzumab
T6	Drug 73 85	mitoxantrone
T7	Drug 90 101	ocrelizumab
*	OR T7 T6 T5 T4 T3
T8	Scope 35 101	fingolimod, natalizumab, alemtuzumab, mitoxantrone and ocrelizumab
R1	Subsumes Arg1:T2 Arg2:T8	
R2	Has_temporal Arg1:T2 Arg2:T1	
T9	Value 104 112	Positive
T10	Measurement 113 124;140 160	hepatitis C surface antigen test
T11	Measurement 128 160	hepatitis B surface antigen test
T12	Measurement 168 197	hepatits B core antibody test
T13	Qualifier 202 224	immunoglobulin G (IgG)
T14	Qualifier 232 254	immunoglobulin M (IgM)
*	OR T13 T14
T15	Scope 202 254	immunoglobulin G (IgG) and/or immunoglobulin M (IgM)
R3	Has_scope Arg1:T12 Arg2:T15	
*	OR T10 T11 T12
T16	Scope 113 254	hepatitis C or hepatitis B surface antigen test and/or hepatits B core antibody test for immunoglobulin G (IgG) and/or immunoglobulin M (IgM)
R4	Has_value Arg1:T16 Arg2:T9	
T17	Temporal 257 264	Current
T18	Temporal 268 284	previous history
T20	Condition 288 315	immune deficiency disorders
T21	Measurement 337 371	human immunodeficiency virus (HIV)
T22	Value 328 336	positive
R5	Has_value Arg1:T21 Arg2:T22	
R6	Subsumes Arg1:T20 Arg2:T21	
*	OR T18 T17
T19	Scope 257 284	Current or previous history
R7	Has_scope Arg1:T20 Arg2:T19	
T23	Procedure 401 418;439 446	immunosuppressive therapy
T24	Procedure 422 446	myelosuppressive therapy
*	OR T24 T23
T25	Temporal 381 390	Currently
T26	Drug 466 487	monoclonal antibodies
T27	Drug 489 501	methotrexate
T28	Drug 503 519	cyclophosphamide
T29	Drug 521 533	cyclosporine
T30	Drug 537 549	azathioprine
T31	Drug 569 584	corticosteroids
T32	Multiplier 554 565	chronic use
R8	Has_multiplier Arg1:T31 Arg2:T32	
*	OR T30 T31 T29 T28 T27 T26
T33	Scope 466 584	monoclonal antibodies, methotrexate, cyclophosphamide, cyclosporine or azathioprine, or chronic use of corticosteroids
T34	Scope 401 446	immunosuppressive or myelosuppressive therapy
R9	Subsumes Arg1:T34 Arg2:T33	
R10	Has_temporal Arg1:T34 Arg2:T25	
T35	Procedure 598 610	tuberculosis
T36	Procedure 632 644	tuberculosis
T37	Procedure 656 668	tuberculosis
T38	Qualifier 649 655	latent
T39	Qualifier 625 631	active
R11	Has_qualifier Arg1:T36 Arg2:T39	
R12	Has_qualifier Arg1:T37 Arg2:T38	
T40	Observation 587 594	History
R13	Has_temporal Arg1:T35 Arg2:T40	
*	OR T35 T36 T37
T41	Condition 693 741	Progressive Multifocal Leukoencephalopathy (PML)
T42	Procedure 745 777	Magnetic Resonance Imaging (MRI)
R14	AND Arg1:T42 Arg2:T41	
T43	Mood 670 678	Evidence
T44	Mood 682 689	suspect
*	OR T44 T43
T45	Scope 670 689	Evidence or suspect
R15	Has_scope Arg1:T41 Arg2:T45	
T46	Observation 801 808	history
T47	Condition 812 822	malignancy
T48	Condition 787 797	malignancy
T49	Qualifier 780 786	Active
R16	Has_temporal Arg1:T47 Arg2:T46	
R17	Has_qualifier Arg1:T48 Arg2:T49	
*	OR T48 T47
T50	Non-representable 825 879	Other protocol defined exclusion criteria could apply.
